The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mccarthy Teresa since 2024.
This trader's CIK number is 1862121.
At the time of last reporting, Mccarthy Teresa was the Chief Human Resources Officer of Avidity Biosciences, Inc.. (stock ticker symbol RNA).
Also see all insider trading activities at Avidity Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RNA | 0 | $0 | 20,737 | $791,826 | 10,000 | $223,400 |
| 2024 | RNA | 0 | $0 | 136,233 | $5,432,984 | 100,000 | $1,422,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | RNA | Option Ex | 10,000 | 22.34 | 223,400 |
| 2025-08-15 | RNA | Sale | 10,000 | 46.56 | 465,630 |
| 2025-03-20 | RNA | Sale | 7,778 | 31.06 | 241,584 |
| 2025-01-21 | RNA | Sale | 2,959 | 28.59 | 84,612 |
| 2024-12-18 | RNA | Sale | 11,151 | 32.66 | 364,191 |
| 2024-12-16 | RNA | Option Ex | 25,000 | 14.22 | 355,500 |
| 2024-12-16 | RNA | Sale | 25,000 | 33.26 | 831,600 |
| 2024-11-18 | RNA | Option Ex | 25,000 | 14.22 | 355,500 |
| 2024-11-18 | RNA | Sale | 25,000 | 41.14 | 1,028,525 |
| 2024-10-16 | RNA | Option Ex | 25,000 | 14.22 | 355,500 |
| 2024-10-16 | RNA | Sale | 25,000 | 48.52 | 1,213,000 |
| 2024-09-23 | RNA | Sale | 13,153 | 44.00 | 578,732 |
| 2024-09-11 | RNA | Option Ex | 25,000 | 14.22 | 355,500 |
| 2024-09-11 | RNA | Sale | 25,000 | 40.40 | 1,010,050 |
| 2024-06-18 | RNA | Sale | 9,864 | 39.13 | 385,968 |
| 2024-01-22 | RNA | Sale | 2,065 | 10.13 | 20,918 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccarthy Teresa (Chief Human Resources Officer of Avidity Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.